Happy Mother's Day! Taking A Look Ahead Watc
Post# of 148179
(Total Views: 624)
Posted On: 05/08/2022 11:59:58 AM
Happy Mother's Day!
Taking A Look Ahead
Watching and waiting. Not just waiting, but also watching and stating what I see. Others too, who watch, as do I can see where we are headed.
Nader was put out, like unto death but not unto death. He had not been able to further himself regardless of the weapon he wielded. He had an inability to fight his foes. He was therefore shut down.
Early celebrations turned dark. The thinking that winning was imminent was hit with RTF and warning letters. Yet, Nader was right on both accounts and they pull ahead on their lies and deception.
Nader escapes by termination. His way out. CytoDyn's way out. Nader's steep monetary draw now eliminated. CytoDyn operates down to the bare minimum. Efficiency rules. We no longer barrel down head long the road with a megaphone announcing every detail and every play. Even the most prized and pertinent details are put away to be appropriately announced at strategic moments. However, what our enemies do not realize remains the same fact that the same power which Nader constantly orated and proclaimed about is the same power which will level them and it grows mightier by the day.
Things are not as it they may appear. Too many would love you to believe that CytoDyn is in dire straights. I believe CytoDyn will say something small about NASH 700 pretty soon. We already know that this will happen in mid-June, but I think we will get something prior to that. It doesn't have to be a complete revelation. It can be partial. Just need to keep them off our backs. We need them to have a taste of the bomb blast that's coming. Just give us a taste CytoDyn, we don't need to eat.
On Amarex, I stand by what I said yesterday. We won't negotiate. There is much behind the BLA they submitted to the FDA on our behalf for the HIV indication. There are perpetrators and big money as well as big pharma behind this act of maleficence. None are immune. All have deep pockets. All will be found out and discovered. The implications of which are enormous. CytoDyn swallows whole the elephant in the room. Negotiations? There will be nothing left to negotiate for, not even half an ear. No crumbs under the table. And Amarex will not be the only one consumed.
It seems like the waters are calm for big pharma's ship. It's smooth sailing right now. All they need to do is to continue to pay interest on the borrowed short shares and they will succeed on keeping the lid on leronlimab. Just, maintain at least the 50 million short shares, keeping the cork in the bottle and keep adding even more than 80% of daily trades as short. Do what ever it takes to keep this thing from blowing, even when the bottle is shaken, when the world wants in, and certainly, do what ever has to be done to keep this pressure cooker down. Therefore do it, they command to their brokers, short it, as long as the word Leronlimab is kept at bay.
CytoDyn shall speak and the bottle shakes. CytoDyn already know what they will say. That time soon approaches.
Sidley Austin shall speak. Their time comes, and is beyond the horizon.
Either one of these or the culmination of the two, but I think it will be sudden rather than a slow upward drip. A sudden spoken word, apt & apropos, brings on the sudden collapse of this tall stack of short suppressive shares and the elimination of any attack and the evaporation of the worst of them as CytoDyn will have engorged itself in their plunder.
That's my conclusion when it comes to Amarex and NASH.
//
Now onto partnerships.
Just to remind you all. I speak with confidence because we own Leronlimab. I have no other reason to be confident other than solely on account of our asset. I take my forwardness because of that drug.
Unless Amarex concludes rapidly and we are awarded a massive windfall, (which I do not perceive happening all that soon, but I know it will come), CytoDyn needs to partner. CytoDyn needs to remain in control of all the partnerships it engages into. The partner needs to understand that it is their privilege to partner with CytoDyn, because Leronlimab causes their drug to be successful. CytoDyn must maintain ownership of the molecule. All partnerships terminate once their drug goes generic. After that, doctors may prescribe their drug alone, Leronlimab alone or still the combination of the drug/the generic with Leronlimab.
Partnerships are the only way, without a massive windfall, to go forward. And that is why I think we need a CEO who already has experience with many big pharmaceuticals and who is respected by them. and who has pertinent contacts with them or he may know many of the pharmaceutical suppliers and supporters and be well credentialed. It will be through this person, that CytoDyn develops into a Big Pharma itself and within his tenure, that CytoDyn greatly expands and morphs into adulthood.
Obstacles? Road blocks? Detours? No. There won't be any.
Everyone will want to be paired up with Leronlimab and that is our opportunity to expand our indication list. Big Pharma's mantra will be, "If you can't beat 'em, join 'em." If you can't beat Leronlimab, then partner with it. CytoDyn decisively takes market share. Shorts will have found greener pastures for months and months already.
CytoDyn needs to remain vigilant. Be careful of the covenants you sign CytoDyn. Leronlimab may not be breached. That must be forbidden. There can be no access to its assembly or manufacturing. There can be no understanding to its formula. There can be no decoding.
If for whatever reason, this is actually breached. all contracts / partnerships cease at once and CytoDyn goes it alone again. That must be written in every contract. Whoever would have breached this will be fighting with their best foot forward to again destroy CytoDyn.
Hope we hear from CytoDyn shortly.
Taking A Look Ahead
Watching and waiting. Not just waiting, but also watching and stating what I see. Others too, who watch, as do I can see where we are headed.
Nader was put out, like unto death but not unto death. He had not been able to further himself regardless of the weapon he wielded. He had an inability to fight his foes. He was therefore shut down.
Early celebrations turned dark. The thinking that winning was imminent was hit with RTF and warning letters. Yet, Nader was right on both accounts and they pull ahead on their lies and deception.
Nader escapes by termination. His way out. CytoDyn's way out. Nader's steep monetary draw now eliminated. CytoDyn operates down to the bare minimum. Efficiency rules. We no longer barrel down head long the road with a megaphone announcing every detail and every play. Even the most prized and pertinent details are put away to be appropriately announced at strategic moments. However, what our enemies do not realize remains the same fact that the same power which Nader constantly orated and proclaimed about is the same power which will level them and it grows mightier by the day.
Things are not as it they may appear. Too many would love you to believe that CytoDyn is in dire straights. I believe CytoDyn will say something small about NASH 700 pretty soon. We already know that this will happen in mid-June, but I think we will get something prior to that. It doesn't have to be a complete revelation. It can be partial. Just need to keep them off our backs. We need them to have a taste of the bomb blast that's coming. Just give us a taste CytoDyn, we don't need to eat.
On Amarex, I stand by what I said yesterday. We won't negotiate. There is much behind the BLA they submitted to the FDA on our behalf for the HIV indication. There are perpetrators and big money as well as big pharma behind this act of maleficence. None are immune. All have deep pockets. All will be found out and discovered. The implications of which are enormous. CytoDyn swallows whole the elephant in the room. Negotiations? There will be nothing left to negotiate for, not even half an ear. No crumbs under the table. And Amarex will not be the only one consumed.
It seems like the waters are calm for big pharma's ship. It's smooth sailing right now. All they need to do is to continue to pay interest on the borrowed short shares and they will succeed on keeping the lid on leronlimab. Just, maintain at least the 50 million short shares, keeping the cork in the bottle and keep adding even more than 80% of daily trades as short. Do what ever it takes to keep this thing from blowing, even when the bottle is shaken, when the world wants in, and certainly, do what ever has to be done to keep this pressure cooker down. Therefore do it, they command to their brokers, short it, as long as the word Leronlimab is kept at bay.
CytoDyn shall speak and the bottle shakes. CytoDyn already know what they will say. That time soon approaches.
Sidley Austin shall speak. Their time comes, and is beyond the horizon.
Either one of these or the culmination of the two, but I think it will be sudden rather than a slow upward drip. A sudden spoken word, apt & apropos, brings on the sudden collapse of this tall stack of short suppressive shares and the elimination of any attack and the evaporation of the worst of them as CytoDyn will have engorged itself in their plunder.
That's my conclusion when it comes to Amarex and NASH.
//
Now onto partnerships.
Just to remind you all. I speak with confidence because we own Leronlimab. I have no other reason to be confident other than solely on account of our asset. I take my forwardness because of that drug.
Unless Amarex concludes rapidly and we are awarded a massive windfall, (which I do not perceive happening all that soon, but I know it will come), CytoDyn needs to partner. CytoDyn needs to remain in control of all the partnerships it engages into. The partner needs to understand that it is their privilege to partner with CytoDyn, because Leronlimab causes their drug to be successful. CytoDyn must maintain ownership of the molecule. All partnerships terminate once their drug goes generic. After that, doctors may prescribe their drug alone, Leronlimab alone or still the combination of the drug/the generic with Leronlimab.
Partnerships are the only way, without a massive windfall, to go forward. And that is why I think we need a CEO who already has experience with many big pharmaceuticals and who is respected by them. and who has pertinent contacts with them or he may know many of the pharmaceutical suppliers and supporters and be well credentialed. It will be through this person, that CytoDyn develops into a Big Pharma itself and within his tenure, that CytoDyn greatly expands and morphs into adulthood.
Obstacles? Road blocks? Detours? No. There won't be any.
Everyone will want to be paired up with Leronlimab and that is our opportunity to expand our indication list. Big Pharma's mantra will be, "If you can't beat 'em, join 'em." If you can't beat Leronlimab, then partner with it. CytoDyn decisively takes market share. Shorts will have found greener pastures for months and months already.
CytoDyn needs to remain vigilant. Be careful of the covenants you sign CytoDyn. Leronlimab may not be breached. That must be forbidden. There can be no access to its assembly or manufacturing. There can be no understanding to its formula. There can be no decoding.
If for whatever reason, this is actually breached. all contracts / partnerships cease at once and CytoDyn goes it alone again. That must be written in every contract. Whoever would have breached this will be fighting with their best foot forward to again destroy CytoDyn.
Hope we hear from CytoDyn shortly.
(14)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼